Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia androgenética is common hair loss affecting self-esteem, treatable with medications and procedures.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Forsythoside A may help treat hair loss by blocking specific channels.

A combined approach of medical treatments, natural remedies, diet, and stress management is best for hair regrowth in Cambodia.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

Advancements in reproductive technologies for carnivores help conserve species and offer insights into human reproductive issues.

Hair loss affects well-being but can be treated with medication or surgery.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

New treatments for hair loss are being researched for better effectiveness and safety.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

The book is a comprehensive and current guide on hair disorders, with minor flaws.

Early diagnosis of Alopecia Frontal Fibrosante is crucial for effective treatment.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Generic drugs for benign prostatic hyperplasia can cost up to 500% more at chain pharmacies compared to independent ones.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Post-finasteride syndrome is rare but serious and should be taken seriously.